Drugs Made In America Acquisition DMII SEC Filings

NASDAQ DMII
$10.16 +0.00 (+0.00%)
As of: Sep 10, 2026 · 3:07 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Drugs Made In America Acquisition II Corp. (DMII) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index